Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

$22.36 +0.13 (+0.56%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$22.35 0.00 (-0.02%)

As of 09/11/2026 07:30 PM Eastern

FMS vs. LH, DGX, GH, BTSG, and TEM

Should you buy Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? Fresenius Medical Care AG & Co. KGaA's main competitors and comparable companies include Labcorp (LH), Quest Diagnostics (DGX), Guardant Health (GH), BrightSpring Health Services (BTSG), and Tempus AI (TEM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Labcorp (NYSE:LH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

Labcorp has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

In the previous week, Labcorp had 21 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 21 mentions for Labcorp and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Labcorp's average media sentiment score of 0.56 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that Labcorp is being referred to more favorably in the media.

Company	Overall Sentiment
Labcorp	Positive
Fresenius Medical Care AG & Co. KGaA	Neutral

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Labcorp currently has a consensus price target of $336.36, indicating a potential upside of 8.03%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, indicating a potential upside of 5.42%. Given Labcorp's stronger consensus rating and higher probable upside, equities analysts clearly believe Labcorp is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Labcorp pays an annual dividend of $2.88 per share and has a dividend yield of 0.9%. Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.61 per share and has a dividend yield of 2.7%. Labcorp pays out 23.8% of its earnings in the form of a dividend. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Labcorp. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95B	1.81	$876.50M	$12.09	25.75
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.58

Labcorp has a net margin of 6.99% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Labcorp's return on equity of 16.74% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.99%	16.74%	7.81%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Summary

Labcorp beats Fresenius Medical Care AG & Co. KGaA on 15 of the 18 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

88.1% of Quest Diagnostics shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Quest Diagnostics had 15 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 15 mentions for Quest Diagnostics and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Quest Diagnostics' average media sentiment score of 1.19 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Quest Diagnostics	Positive
Fresenius Medical Care AG & Co. KGaA	Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Quest Diagnostics. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.04B	2.35	$992M	$9.42	24.93
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.58

Quest Diagnostics currently has a consensus target price of $236.31, suggesting a potential upside of 0.64%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, suggesting a potential upside of 5.42%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Quest Diagnostics has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Quest Diagnostics pays an annual dividend of $3.44 per share and has a dividend yield of 1.5%. Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.61 per share and has a dividend yield of 2.7%. Quest Diagnostics pays out 36.5% of its earnings in the form of a dividend. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Quest Diagnostics has increased its dividend for 14 consecutive years. Fresenius Medical Care AG & Co. KGaA is clearly the better dividend stock, given its higher yield and lower payout ratio.

Quest Diagnostics has a net margin of 9.18% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Quest Diagnostics' return on equity of 16.01% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.18%	16.01%	7.27%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Summary

Quest Diagnostics beats Fresenius Medical Care AG & Co. KGaA on 14 of the 20 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

Guardant Health presently has a consensus price target of $188.13, suggesting a potential upside of 19.54%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, suggesting a potential upside of 5.42%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts clearly believe Guardant Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	24 Buy rating(s)	1 Strong Buy rating(s)	2.96
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Guardant Health has a beta of 1.57, suggesting that its stock price is 57% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Guardant Health's net margin of -38.33%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

In the previous week, Guardant Health had 18 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 18 mentions for Guardant Health and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Guardant Health's average media sentiment score of 0.93 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that Guardant Health is being referred to more favorably in the media.

Company	Overall Sentiment
Guardant Health	Positive
Fresenius Medical Care AG & Co. KGaA	Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	21.51	-$416.28M	-$3.49	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.58

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Guardant Health beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.90	$190.67M	$1.66	35.38
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.58

BrightSpring Health Services has a beta of 1.84, indicating that its stock price is 84% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.55%	16.73%	5.24%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

In the previous week, BrightSpring Health Services had 6 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for BrightSpring Health Services and 0 mentions for Fresenius Medical Care AG & Co. KGaA. BrightSpring Health Services' average media sentiment score of 1.24 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Overall Sentiment
BrightSpring Health Services	Positive
Fresenius Medical Care AG & Co. KGaA	Neutral

BrightSpring Health Services presently has a consensus target price of $70.71, indicating a potential upside of 20.39%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, indicating a potential upside of 5.42%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, equities research analysts plainly believe BrightSpring Health Services is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 12 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Tempus AI (NASDAQ:TEM) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

24.2% of Tempus AI shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Tempus AI presently has a consensus price target of $69.33, indicating a potential upside of 17.49%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, indicating a potential upside of 5.42%. Given Tempus AI's stronger consensus rating and higher possible upside, equities analysts clearly believe Tempus AI is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	8 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.43
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	8.37	-$245.03M	-$1.44	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.58

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Tempus AI's net margin of -17.77%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

In the previous week, Tempus AI had 30 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 30 mentions for Tempus AI and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Tempus AI's average media sentiment score of 0.63 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that Tempus AI is being referred to more favorably in the media.

Company	Overall Sentiment
Tempus AI	Positive
Fresenius Medical Care AG & Co. KGaA	Neutral

Tempus AI has a beta of 3.72, meaning that its share price is 272% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

Summary

Tempus AI beats Fresenius Medical Care AG & Co. KGaA on 9 of the 16 factors compared between the two stocks.

Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FMS vs. The Competition

Export

Metric	Fresenius Medical Care AG & Co. KGaA	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$12.00B	$9.84B	$7.17B	$23.39B
Dividend Yield	2.71%	2.61%	2.57%	3.56%
P/E Ratio	11.58	33.53	274.94	28.71
Price / Sales	0.54	4.89	685.45	21.10
Price / Cash	4.02	125.15	76.65	34.17
Price / Book	0.77	5.29	10.33	4.74
Net Income	$1.11B	$313.25M	$3.50B	$1.07B
7 Day Performance	-1.35%	-1.26%	-3.32%	-2.00%
1 Month Performance	-5.71%	-0.98%	-0.41%	-2.69%
1 Year Performance	-10.47%	15.13%	19.21%	10.45%

Fresenius Medical Care AG & Co. KGaA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FMS Fresenius Medical Care AG & Co. KGaA	2.176 of 5 stars	$22.36 +0.6%	$23.57 +5.4%	-11.6%	$12.00B	$22.20B	11.58	1,488
LH Labcorp	4.1155 of 5 stars	$333.61 -0.4%	$330.00 -1.1%	+11.2%	$27.18B	$13.95B	27.59	71,000	Trending News Analyst Forecast
DGX Quest Diagnostics	4.4194 of 5 stars	$240.96 -0.7%	$235.31 -2.3%	+27.8%	$26.79B	$11.04B	25.58	57,000	Positive News Analyst Forecast Analyst Revision
GH Guardant Health	3.3292 of 5 stars	$159.02 -1.5%	$183.78 +15.6%	+177.1%	$21.67B	$982.02M	N/A	2,506	Analyst Forecast
BTSG BrightSpring Health Services	4.6035 of 5 stars	$58.40 -1.2%	$70.71 +21.1%	+109.8%	$11.70B	$12.91B	35.18	23,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:FMS) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

FMS vs. LH, DGX, GH, BTSG, and TEM

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS vs. The Competition

Fresenius Medical Care AG & Co. KGaA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

FMS vs. LH, DGX, GH, BTSG, and TEM

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Which has more risk & volatility, LH or FMS?

Does the media prefer LH or FMS?

Do insiders and institutionals have more ownership in LH or FMS?

Do analysts rate LH or FMS?

Is LH or FMS a better dividend stock?

Which has higher valuation & earnings, LH or FMS?

Is LH or FMS more profitable?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Do institutionals and insiders believe in DGX or FMS?

Does the media prefer DGX or FMS?

Which has higher earnings and valuation, DGX or FMS?

Do analysts rate DGX or FMS?

Which has more volatility & risk, DGX or FMS?

Is DGX or FMS a better dividend stock?

Is DGX or FMS more profitable?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Do analysts rate GH or FMS?

Which has more volatility & risk, GH or FMS?

Is GH or FMS more profitable?

Does the media favor GH or FMS?

Which has preferable earnings & valuation, GH or FMS?

Do insiders and institutionals believe in GH or FMS?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

Do institutionals & insiders believe in BTSG or FMS?

Which has better earnings & valuation, BTSG or FMS?

Which has more risk & volatility, BTSG or FMS?

Is BTSG or FMS more profitable?

Does the media refer more to BTSG or FMS?

Do analysts prefer BTSG or FMS?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Do insiders & institutionals have more ownership in TEM or FMS?

Do analysts prefer TEM or FMS?

Which has stronger earnings and valuation, TEM or FMS?

Is TEM or FMS more profitable?

Does the media prefer TEM or FMS?

Which has more volatility & risk, TEM or FMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS vs. The Competition

Fresenius Medical Care AG & Co. KGaA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools